Early Changes in Tumor Size in Patients Treated for Advanced Stage Nonsmall Cell Lung Cancer Do Not Correlate With Survival

被引：2
|
作者：
Oxnard, Geoffrey R. [1 ]
Schwartz, Lawrence H. [2 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Radiol, New York, NY 10021 USA
来源：
CANCER | 2010年 / 116卷 / 06期
关键词：
D O I：
10.1002/cncr.24803
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1615 / 1615
页数：1
相关论文
共 50 条
  • [41] Role of gender in the survival of surgical patients with nonsmall cell lung cancer
    Scaglia, Noris C.
    Chatkin, Jose M.
    Pinto, Jose A.
    Tsukazan, Maria T. R.
    Wagner, Mario B.
    Saldanha, Adriana F.
    ANNALS OF THORACIC MEDICINE, 2013, 8 (03) : 142 - 147
  • [42] Do Surrogate Endpoints Better Correlate with Overall Survival in Studies That Did Not Allow for Crossover or Reported Balanced Postprogression Treatments? An Application in Advanced NonSmall Cell Lung Cancer
    Hashim, Mahmoud
    Pfeiffer, Boris M.
    Bartsch, Robert
    Postma, Maarten
    Heeg, Bart
    VALUE IN HEALTH, 2018, 21 (01) : 9 - 17
  • [43] Survival in locally advanced nonsmall cell lung cancer is related to palliative radiotherapy dose
    Price, A
    Burt, PA
    Gaze, MN
    Gregor, A
    Kerr, GR
    Rees, GJG
    Stout, R
    BRITISH JOURNAL OF CANCER, 1999, 80 : 15 - 15
  • [44] Telomere Length Of Tumor Tissues And Survival In Patients With Early Stage Non-Small Cell Lung Cancer
    Choi, E.
    Son, J. W.
    Jeon, H. S.
    Lee, E. B.
    Park, J. Y.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [45] Telomere length of tumor tissues and survival in patients with early stage non-small cell lung cancer
    Jeon, Hyo-Sung
    Choi, Yi Young
    Choi, Jin Eun
    Lee, Won Kee
    Lee, Eungbae
    Yoo, Seung Soo
    Lee, Shin Yup
    Lee, Jaehee
    Cha, Seung Ick
    Kim, Chang Ho
    Park, Jae Yong
    MOLECULAR CARCINOGENESIS, 2014, 53 (04) : 272 - 279
  • [46] Unsupervised Machine Learning of Radiomic Features for Predicting Treatment Response and Survival of Early-Stage Nonsmall Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy
    Li, H.
    Galperin-Aizenberg, M.
    Pryma, D. A.
    Simone, C. B., II
    Fan, Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : S34 - S34
  • [47] Phase 1 study of epacadostat in combination with atezolizumab for patients with previously treated advanced nonsmall cell lung cancer
    Hellmann, Matthew D.
    Gettinger, Scott
    Chow, Laura Q. M.
    Gordon, Michael
    Awad, Mark M.
    Cha, Edward
    Gong, Xiaohua
    Zhou, Gongfu
    Walker, Chris
    Leopold, Lance
    Heist, Rebecca S.
    INTERNATIONAL JOURNAL OF CANCER, 2020, 147 (07) : 1963 - 1969
  • [48] Prognostic Value of Symptom Burden for Overall Survival in Patients Receiving Chemotherapy for Advanced Nonsmall Cell Lung Cancer
    Wang, Xin Shelley
    Shi, Qiuling
    Lu, Charles
    Basch, Ethan M.
    Johnson, Valen E.
    Mendoza, Tito R.
    Mobley, Gary M.
    Cleeland, Charles S.
    CANCER, 2010, 116 (01) : 137 - 145
  • [49] The impact of age on toxicity, response rate, quality of life, and survival in patients with advanced, stage IIIB or IV nonsmall cell lung carcinoma treated with carboplatin and paclitaxel
    Hensing, TA
    Peterman, AH
    Schell, MJ
    Lee, JH
    Socinski, MA
    CANCER, 2003, 98 (04) : 779 - 788
  • [50] Serum tumor markers as predictors for survival in advanced non-small cell lung cancer patients treated with gefitinib
    Chiu, Chao-Hua
    Shih, Yu-Ning
    Tsai, Chun-Ming
    Liou, Jia-Ling
    Chen, Yuh-Min
    Perng, Reury-Perng
    LUNG CANCER, 2007, 57 (02) : 213 - 221
12345